Strategies to Shorten the Long and Winding Road to Accurate IPF Diagnosis and Effective Management

Released On
November 30, 2020

Expires On
November 30, 2021

Media Type
Internet

Completion Time
60 minutes

Specialty
Pathology, Pharmacy, Primary Care, Pulmonology, Radiology

Topic(s)
Pulmonary Fibrosis

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Paradigm Medical Communications, LLC.


This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc..

Credit Available

  • Physicians — maximum of 1.00 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 Contact Hours

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity has been designed to address the educational needs of pulmonologists, radiologists, and pathologists. It may also benefit primary care physicians, PAs, nurse practitioners, nurses, pharmacists, fellows, residents, and other allied healthcare providers who are interested or involved in the care of patients with interstitial lung diseases (ILDs).

Program Overview

Swift identification and optimal management of interstitial lung disease (ILD) has become a more urgent priority since with the emergence of COVID-19, which significantly increases the risk of complications and death in this vulnerable patient population. Join us for this timely educational initiative, featuring videos of the foremost ILD experts in the country demonstrating the multidisciplinary approach needed to arrive at an efficient differential diagnosis and optimal treatment, with a focus on idiopathic pulmonary fibrosis (IPF) versus connective tissue disease-related ILD. Video segments of patient perspectives will be shown throughout to highlight the high impact of IPF.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Differentiate idiopathic pulmonary fibrosis (IPF) from other common ILDs, such as connective tissue disease ILD (CTD-ILD), accurately and efficiently using recommended clinical evaluation, radiologic testing, and pathologic testing as needed
  • Apply evidence informing the use of antifibrotic therapy, nonpharmacologic strategies, and management of risk factors and comorbidities in patients with IPF to formulate treatment plans
  • Individualize treatment of IPF based on patient characteristics and preferences, using shared decision-making

Agenda

  • Introduction: The “Alphabet Soup” of ILDs
  • Differential Diagnosis of ILDs
  • Managing IPF: Comprehensive, Patient-Centered Care
  • Q&A

Steering Committee and Faculty

Lisa H. Lancaster, MD

Medical Director, Interstitial Lung Disease Program
Associate Professor of Medicine
Division of Allergy, Pulmonary and Critical Care Medicine
Vanderbilt University Medical Center
Nashville, TN

Steven D. Nathan, MD

Professor of Medicine
Virginia Commonwealth University
Inova Fairfax Campus
Medical Director, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital
Falls Church, VA

Contributing Clinical Faculty

Maria C. Albano, MD

Body Imaging Section Chief
Fairfax Radiological Consultants, PC
Fairfax, VA

Haresh Mani, MD

Staff Pathologist
Inova Fairfax Hospital
Falls Church, VA

Patient Faculty

Richard S. DiLoreto

Clearwater, FL

Physician Accreditation Statement

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

Paradigm Medical Communications, LLC designates this live internet activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Continuing Education

PAs may claim a maximum of 1.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioner Continuing Education

The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Disclosures of Conflicts of Interest

In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below. Any potential conflicts have been resolved.

Lisa H. Lancaster, MD

  • Consulting Fees: Galapagos NV; Genentech, Inc
  • Speakers Bureau: Boehringer Ingelheim Pharmaceuticals, Inc; Genentech, Inc
  • Grant/Research Support: Boehringer Ingelheim Pharmaceuticals, Inc; Celgene Corporation; Galapagos NV; Galecto Biotech; Novartis Corporation; Respirent Pharmaceuticals Co, Ltd

Steven D. Nathan, MD

  • Consulting Fees: Boehringer Ingelheim Pharmaceuticals, Inc; Genentech, Inc
  • Speakers Bureau: Boehringer Ingelheim Pharmaceuticals, Inc; Genentech, Inc

Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.

Independent peer, resident/fellow, and patient reviewers have no financial relationships to disclose.

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.

Instructions for Participation and Credit

To receive a CME certificate of participation, you should:

  • Follow instructions to register or log in with your professional information and complete the pre-activity assessment
  • View the online activity in its entirety
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949 or cme@paradigmmc.com.

There is no fee required for participation in this activity.

Course Viewing Requirements

Hardware/Software Requirements
This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.

Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+

PDF documents
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here: http://get.adobe.com/reader

Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.

Disclaimer

This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.

Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.

Privacy policy
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website"). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Information

If you have any questions or comments, please email us at contactus@paradigmmc.com.

©2020 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.